Resistell among 10 promising European medtech startups to watch in 2020

Resistell has closed an oversubscribed seed financing round. Lead Investor Occident Group AG, Hemex AG and six other private investors invested in the EPFL spin-off developing the world’s fastest phenotypic antibiotic susceptibility test.

Resistell AG a finalist of the Swiss Technology Award 2018!

Resistell wins the MassChallenge Switzerland 2018 Gold Award

Warning comes as report shows 3 million common surgical procedures could be hazardous if infections become resistant to antibiotics

Join us at the annual meeting of the Swiss Society for Microbiology held within the CHUV, Lausanne.

New treatments like phage therapy are being used to fight the deadly risk of antibiotic resistance, and Resistell is working to speed up and improve the identification of bacteria and the prescription of the correct medicines.

We are please to share that on 07.06.2018 in Zurich, Resistell has received the Swiss Nanotechnology Startup Award for the Best Nanotechnology Startup 2018.